Gut microbiota: An overlooked target in dyslipidemia management

doi:10.3748/wjg.v31.i48.113178

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 48

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Sum=100

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=14

Dec 28, 2025 (publication date) through Dec 27, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Gastroenterol. Dec 28, 2025; 31(48): 113178
Published online Dec 28, 2025. doi: 10.3748/wjg.v31.i48.113178

Open in New Tab Full Size Figure Download Figure

Figure 1 Key functional pathways in dyslipidemia. BA: Bile acid; FXR: Farnesoid X receptor; TGR5: Takeda G protein-coupled receptor 5; LDL: Low-density lipoprotein; SCFAs: Short-chain fatty acids; LPS: Lipopolysaccharide; TMAO: Trimethylamine-N-Oxide; TMA: Trimethylamine; CVD: Chemical vapor deposition; LDL-C: Low-density lipoprotein cholesterol.

Citation: Majeed AA, Butt AS. Gut microbiota: An overlooked target in dyslipidemia management. World J Gastroenterol 2025; 31(48): 113178
URL: https://www.wjgnet.com/1007-9327/full/v31/i48/113178.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i48.113178